Feasibility and sociopsychological impact of video consultations in medical oncology - a randomized controlled open label trial

Thomas Walle, Erkin Erdal, Leon Mühlsteffen, Hans Martin Singh, Editha Gnutzmann, Barbara Grün, Helene Hofmann, Alexandra Ivanova, Bruno Köhler, Felix Korell, Athanasios Mavratzas, Andreas Möck, Constantin Pixberg, David Schult, H Starke, Niels Steinebrunner, Lena Woydack, Andreas Schneeweiß, Mareike Dietrich, Dirk Jäger, Johannes Krisam, Jakob Nikolas Kather, Eva C. WinklermedRxiv 2020 · DOI

Abstract

Background: Mobile phone video call applications generally did not undergo testing in randomized controlled clinical trials prior to their implementation in patient care regarding the rate of successful patient visits and impact on the physician-patient relationship. Methods: The NCT MOBILE trial was a monocentric open-label randomized controlled clinical trial of patients with solid tumors undergoing systemic cancer therapy with need of a follow-up visit with their consulting physician at outpatient clinics. 66 patients were 1:1 randomized to receive either a standard in-person follow-up visit at outpatient clinics or a video call via a mobile phone application. The primary outcome was feasibility defined as the number of successful appointments at the first follow up visit. Findings: Success rate of the first follow up visit in the intention-to-treat cohort was 87.8% for in-person visits and 78.7% for video calls (p=0.51, RR=0.88-1.43 95%CI). Standardized patient questionnaires showed significantly decreased total time spent and less direct costs for patients and comparable time spent for physicians in the video call arm. Doctor-patient relationship quality mean scores (QQPPI) were higher in the video call arm (1.12 fold, p=0.02). Interpretation: Follow-up visits with the tested mobile phone video call application were feasible but software compatibility should be critically evaluated.

Introduction

Patients diagnosed with solid tumors often face a grueling schedule of systemic therapies, necessitating frequent follow-up visits. For many, these appointments require long commutes to specialized cancer centers—a burden often referred to as "time toxicity." In palliative care settings, travel and wait times can consume up to 10% of a patient's remaining "awake time."

While telemedicine offers a potential solution to reduce this burden, the rapid adoption of video-call applications in oncology has often bypassed rigorous clinical validation. Concerns persist regarding the technical reliability of these platforms and whether the lack of physical presence might erode the physician-patient relationship. The NCT MOBILE trial was designed to address these concerns through a randomized controlled framework.

Methodology

The NCT MOBILE trial was a monocentric, open-label randomized controlled trial (RCT) conducted at the National Center for Tumor Diseases (NCT) in Heidelberg. The study enrolled 66 patients with solid tumors (ECOG performance status 0-2) who required a follow-up visit within a 2-to-14-day window.

Participants were randomized 1:1 into two groups:

  1. In-Person Arm: Standard follow-up at the outpatient clinic.
  2. Video Arm: Consultation via the "Minxli – Arzt via Video Chat" smartphone application.

Researchers evaluated feasibility as the primary outcome, defined by the success rate of the first scheduled appointment. Secondary outcomes included the success of subsequent calls, time and cost efficiency for patients, physician workload, and the quality of the physician-patient relationship as measured by the validated Questionnaire on Quality of Physician-Patient Interaction (QQPPI).

Key Findings

Feasibility and Technical Barriers

The study found that video consultations are a viable alternative to in-person visits, though they face unique hurdles. The success rate for the first follow-up was 87.8% for the in-person arm compared to 78.7% for the video arm. While the video arm's success rate was lower, the difference was not statistically significant (p=0.51).

Interestingly, the reasons for failure differed by medium: video call failures were primarily due to software or hardware incompatibility (12%), whereas in-person failures were typically caused by patient "no-shows" (6%). For patients who successfully navigated the first video call, the success rate for subsequent appointments rose to 91.6%, suggesting a learning curve for the technology.

Impact on Patient Experience and Relationship Quality

One of the most striking findings was the impact on the physician-patient relationship. Contrary to the fear that digital screens create a sense of detachment, the QQPPI scores were significantly higher in the video call arm (1.12-fold higher, p=0.02).

Researchers proposed an "Exclusivity Hypothesis" to explain this: the direct digital link may provide a sense of privacy and undivided attention that is often missing in the high-volume, hectic environment of a physical outpatient clinic. Furthermore, patient demand for these services was high; during screening, 9% of eligible patients refused to participate because they were only interested in the video call option.

Efficiency Gains

Telemedicine provided substantial resource savings for patients without increasing the burden on healthcare providers:

  • Time Savings: Patients in the video arm saved an average of 170 minutes in total time.
  • Cost Savings: Direct travel costs were reduced by approximately €14.37, while indirect costs (such as lost wages) were reduced by €61.28.
  • Physician Workload: The time spent by physicians remained comparable between both arms, indicating that telemedicine does not necessarily extend the duration of the consultation.

Discussion and Limitations

While the NCT MOBILE trial supports the feasibility of video consultations, several limitations must be considered. With a sample size of 66, the study was not powered as a non-inferiority trial. Additionally, the requirement for smartphone ownership may have introduced a selection bias, potentially excluding less tech-savvy or older populations.

Furthermore, the study focused on routine follow-ups where a relationship had already been established. The authors caution that video calls may be less appropriate for initial consultations or for delivering sensitive news. Finally, the study did not assess long-term clinical outcomes; since physical exams were performed in 30% of in-person visits but only 9% of video visits, further research is needed to ensure that the lack of physical touch does not lead to missed clinical signals.

Conclusion

The NCT MOBILE trial demonstrates that video consultations are not only feasible in medical oncology but can also improve the perceived quality of the physician-patient interaction while significantly reducing the time and financial burden on patients. As technical infrastructure improves and software compatibility issues are addressed, telemedicine is poised to become an essential tool in patient-centered cancer care.

Summary updated

Abstract

Abstract Background Mobile phone video call applications generally did not undergo testing in randomized controlled clinical trials prior to their implementation in patient care regarding the rate of successful patient visits and impact on the physician-patient relationship. Methods The NCT MOBILE trial was a monocentric open-label randomized controlled clinical trial of patients with solid tumors undergoing systemic cancer therapy with need of a follow-up visit with their consulting physician at outpatient clinics. 66 patients were 1:1 randomized to receive either a standard in-person follow-up visit at outpatient clinics or a video call via a mobile phone application. The primary outcome was feasibility defined as the number of successful appointments at the first follow up visit. Secondary outcomes included success rate of further video calls, time spent by patient and physician, patient satisfaction, and quality of physician-patient relationship. Findings Success rate of the first follow up visit in the intention-to-treat cohort was 87.8% for in-person visits and 78.7% for video calls (p=0.51, RR=0.88-1.43 95%CI). The most common reasons for failure were software incompatibility (12%) in the video call and no-show (6%) in the in-person visit arm. The success rate for further video visits was 91.6% (11 of 12 calls). Standardized patient questionnaires showed significantly decreased total time spent and less direct costs for patients (Δ95 to 246min 95%CI, Δ4.8 to 23.9€ 95%CI) and comparable time spent for physicians in the video call arm (Δ-6.4 to 5.4min, 95%CI). Doctor-patient relationship quality mean scores assessed by the validated standardized “questionnaire on quality of physician-patient interaction”(QQPPI) were higher in the video call arm (video call/in-person = 1.12 fold, p=0.02). Interpretation Follow-up visits with the tested mobile phone video call application were feasible but software compatibility should be critically evaluated. Trial registration Retrospectively registered in the German Clinical Trials Register DRKS00015788, 26 th October 2018
BibTeX
@misc{walle2020feasibility,
  author = {Thomas Walle and Erkin Erdal and Leon Mühlsteffen and Hans Martin Singh and Editha Gnutzmann and Barbara Grün and Helene Hofmann and Alexandra Ivanova and Bruno Köhler and Felix Korell and Athanasios Mavratzas and Andreas Möck and Constantin Pixberg and David Schult and H Starke and Niels Steinebrunner and Lena Woydack and Andreas Schneeweiß and Mareike Dietrich and Dirk Jäger and Johannes Krisam and Jakob Nikolas Kather and Eva C. Winkler},
  title = {{Feasibility and sociopsychological impact of video consultations in medical oncology - a randomized controlled open label trial}},
  year = {2020},
  doi = {10.1101/2020.07.10.20150052},
  howpublished = {medRxiv},
}
Figure